Delta Sleep-Inducing Peptide — Nonapeptide
A naturally occurring 9-amino acid peptide first isolated from rabbit brain blood in 1977 and named for its ability to induce slow-wave delta sleep. Beyond sleep, DSIP research documents roles in stress regulation, cortisol modulation, neuroprotection, and anti-convulsant activity. The evidence base is modest — predominantly European research from the 1980–2000s — and the mechanism is not fully characterised. Community interest outpaces the clinical data, and DSIP should be approached with appropriate epistemic humility.
01 — Research Summary
DSIP's evidence base is characterised by a burst of research activity in the 1980s and 1990s followed by relative dormancy, with a modest revival of interest in the modern biohacking era. The sleep data is consistent; everything else is less certain.
Delta sleep induction confirmed — the foundational paper. The original Swiss research team isolated DSIP from rabbit brain venous blood during slow-wave sleep stimulation, demonstrating its ability to induce delta sleep activity when infused into recipient rabbits — establishing the compound and its name.
DSIP reduced stress-induced cortisol elevation in humans. A human study documented DSIP administration reduced cortisol levels under stress conditions, suggesting a role in HPA axis modulation alongside its sleep effects — an early indication of broader stress regulatory function.
Significant anti-convulsant effects in multiple seizure models. Multiple animal models showed DSIP had meaningful anti-convulsant properties — an effect not anticipated from its sleep-inducing characterisation and suggesting broader CNS regulatory activity than the name implies.
Consistent sleep-promoting effects across multiple study designs. A modern review of DSIP research confirmed consistent sleep-promoting effects across study types, while noting the mechanistic uncertainty and calling for updated research using modern methodology to validate older findings.
02 — Mechanism of Action
DSIP's mechanism is genuinely not fully understood — which is unusual to acknowledge but important for calibrating expectations. The sleep and stress effects are consistent; the molecular pathway is less clear.
DSIP appears to function as an endogenous sleep-promoting signal that accumulates during waking and contributes to sleep pressure. Its concentration in cerebrospinal fluid follows circadian patterns — higher before sleep, lower on waking — consistent with a physiological sleep regulatory role.
The primary documented effect is promotion of slow-wave (delta) sleep — the deep, restorative sleep phase important for memory consolidation, growth hormone secretion, and immune function. The mechanism of delta wave induction is not fully characterised at the molecular level.
DSIP modulates the hypothalamic-pituitary-adrenal (HPA) axis — the stress response system. It appears to normalise cortisol secretion patterns and reduce stress-induced HPA overactivation, which may explain both its stress-regulatory effects and its promotion of restorative sleep.
Some research suggests DSIP interacts with opioid receptors — potentially explaining its anxiolytic and pain-modulating properties observed in some studies. This interaction may also contribute to its sleep-promoting effects through endorphin-related pathways.
DSIP is a compound where the community enthusiasm exceeds the evidence. The sleep effects are real and consistent across the dataset. The stress and cortisol effects are plausible and documented in human data. Beyond that — the neuroprotection, anti-aging, and other claimed effects — the evidence is thin. DSIP is worth considering if sleep and stress regulation are the primary goals, with realistic expectations about what the evidence actually supports.
03 — Dosing Protocols
DSIP is typically administered by injection or nasal spray. Oral bioavailability is considered poor due to peptide degradation. Doses are derived from research and community protocols.
| Protocol | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Injectable — standard | 100–300 mcg | Before sleep | As needed / 5–10 day cycles | Most commonly reported community dose. Subcutaneous injection 30–60 min before sleep. |
| Nasal spray | 100–200 mcg | Before sleep | As needed | Nasal route for CNS delivery. Some community preference for convenience over injection. |
| Stress regulation | 100–200 mcg | Morning or as needed | Short cycles | Some users dose for stress regulation rather than sleep — timing adjusted accordingly. |
DSIP has a generally favourable safety profile in published research. Mild dizziness and sedation are the primary reported effects at higher doses. The evidence base is older and methodologically inconsistent by modern standards — treat claims about non-sleep effects with appropriate caution. Not FDA-approved for any indication.
04 — Community Experiences
DSIP has a niche community — primarily users interested in sleep optimisation who have already explored mainstream approaches and want something more targeted. r/Peptides and dedicated sleep forums are the main discussion venues. The compound is frequently mentioned alongside other sleep peptides and compared to pharmaceutical sleep aids, with most community members valuing its natural mechanism over synthetic alternatives.
These are user-reported experiences from public forums. Not endorsed by Whats That Peptide and should not be interpreted as clinical evidence. Individual results vary. Always consult a healthcare professional.
"Sleep onset faster. Delta sleep feels deeper — I wake up more restored. Not as strong as pharmaceutical sleep aids but without the dependency risk or cognitive blunting the next day. The natural mechanism is the main appeal for me..."
"The sleep data is solid. The anti-aging and neuroprotection claims are a stretch from the evidence. If you want a natural sleep peptide with decent research behind the core claim, DSIP delivers. Don't expect it to do everything the internet says it does..."
"DSIP is specifically for delta sleep architecture. Melatonin handles sleep onset. BPC-157 can help if stress is the underlying issue. GHK-Cu + DSIP for sleep quality and restoration is my current protocol. Different compounds, different mechanisms..."
"Nasal is easier but injection feels more reliable in effect. The convenience of nasal makes it more sustainable as a nightly practice. Injectable for acute sleep debt recovery, nasal for ongoing maintenance..."